1. Introduction {#sec1-ijerph-17-00938}
===============

The role of vitamins is well known in a medical perspective, but the scientific evidence regarding the oral health perspective is still not fully clarified \[[@B1-ijerph-17-00938]\].

Vitamins are catalysts for all metabolic reactions, using proteins, fats and carbohydrates for energy, growth and cell maintenance. As only small amounts of these fundamental substances are obtained from food, vitamins are often administered though food supplements \[[@B2-ijerph-17-00938]\]. Fat-soluble vitamins such as A, C, D, E and K can be stored in the liver and fat tissues as reserves, while water-soluble vitamins as B and C are expelled if not absorbed.

It is general knowledge that vitamins play a significant effect on oral and general health where its imbalance leads to malnutrition. The process of chewing allows one to extract the greatest possible amount of nutrients and the number and distribution of teeth influence the chewing efficacy. The available literature on the role of vitamins toward oral health is really scarce with no available data on the prevalence of oral disease related to vitamin deficiencies. Teeth loss affects dietary choice and nutritional status \[[@B3-ijerph-17-00938]\]. A significant improvement of vitamin D levels was obtained in partially dentate patients aged ≥ 65 years after the replacement of lost teeth using prosthetic solutions \[[@B4-ijerph-17-00938]\]; still, no strong evidence on the effect of tooth loss on nutritional status was found in a recent review \[[@B5-ijerph-17-00938]\].

Vitamin deficiency prompted several non-specific oral conditions as glossitis, stomatitis and mucosal ulceration. Glossitis with linear lesions was postulated to be an early sign of vitamin B12 paucity \[[@B6-ijerph-17-00938]\].

Vitamin D deficiency leads to reduced bone density, osteoporosis, and, as consequence, to the progression of periodontal disease; on the other hand, sufficient levels of this vitamin might reduce the risk of gingivitis and periodontitis; the vitamin acting as immunomodulator, anti-inflammatory and antiproliferative agent \[[@B7-ijerph-17-00938]\].

In the developmental phases, hard dental tissues are strongly influenced by nutritional status and consequently to vitamin deficiency \[[@B8-ijerph-17-00938]\]. A positive relationship between malnutrition, enamel hypoplasia and caries in the primary dentition was postulated in children \[[@B9-ijerph-17-00938],[@B10-ijerph-17-00938]\].

The frequent and prolonged exposure to acidic agents contained in food, beverages, drugs or food supplements can lead to significant tooth wear \[[@B11-ijerph-17-00938]\]. Chewable vitamin C tablets have been reported to have a pH of about 2, lower than the critical pH value (5.5) for enamel dissolution, postulating an association between vitamin C and erosion with an odds ratio of 1.16 \[[@B12-ijerph-17-00938]\].

The aim of the present study was to perform a systematic review and meta-analysis of the scientific papers published during the last 20 years, investigating the association between vitamins and gingival/periodontal disease and hard dental pathological processes such as dental caries, tooth wear and developmental defects.

2. Materials and Methods {#sec2-ijerph-17-00938}
========================

Reporting of this review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline \[[@B13-ijerph-17-00938]\]. The review protocol was registered with the International prospective register of systematic reviews (PROSPERO) system (ID 150613, 12 September 2019).

2.1. Eligibility Criteria {#sec2dot1-ijerph-17-00938}
-------------------------

The review included randomized controlled trials (RCTs), cross-sectional studies, comparative studies, validation studies and evaluation studies, reporting vitamins supplementary (foods, tablets etc) or vitamin serum levels in patients of any age. Only papers in English published from 1 January 2000 to 30 November 2019 were collected. Electronically published articles and paper-based article were taken into consideration.

2.2. Information Sources {#sec2dot2-ijerph-17-00938}
------------------------

Electronic databases Medline via PubMed, Embase via Ovid and Scopus were screened for articles.

2.3. Information Sources and Search Strategy {#sec2dot3-ijerph-17-00938}
--------------------------------------------

Several search strategies were used. The first included a combination of Medical Subject Headings (MeSH) terms and key words: *Vitamin* OR *Vitamins* OR *oral health*, OR *caries* OR *dental caries* OR *periodontal disease* OR *dental erosion* OR *gingivitis*. The second strategy included the search string "*Vitamins* OR *Vitamin* OR *vitamin A* OR *Vitamin B* OR *Vitamin C* OR *Vitamin D* OR *Vitamins B* OR *Vitamin E* OR *Vitamin K*" and "*Oral health* OR *oral health* OR *caries* OR *dental caries* OR *root caries* OR *tooth diseases* OR *salivation* OR *saliva* OR *periodontal diseases* OR '*dental erosion*' OR *tooth erosion* OR *tooth erosion* OR '*cariogenic bacteria'* OR *biofilms* OR *biofilm* OR *periodontitis* OR *periodontitis* OR *gingivitis* OR *gingivitis* OR *dental plaque* OR *plaque*". Cross-referencing was performed using the bibliographies of full-text articles. Grey literature was also retrieved via opengrey.eu (<http://www.opengrey.eu>).

2.4. Study Selection {#sec2dot4-ijerph-17-00938}
--------------------

Repeated or duplicate papers were excluded after comparing the results from the different research strategies. Three authors (T.G.W., M.G.C., and N.C.) independently examined all the abstracts of the papers. All the papers meeting the inclusion criteria were obtained in the full-text format. The authors independently assessed the papers to establish whether each paper should or should not be included in the systematic review.

2.5. Data Collection, Summary Measures and Synthesis of Results {#sec2dot5-ijerph-17-00938}
---------------------------------------------------------------

Data collection and synthesis was independently carried out by three authors (G.C., M.G.C. and N.C.) using an ad hoc designed data extraction form, without masking journal title or authors. Different studies outcomes were compared on the use of vitamins to prevent or treat oral diseases per different diseases and publication years. To facilitate the synthesis, the results were summarised in tables where each selected paper was included and the main aspects presented (i.e., vitamin and oral disease studies, sample, age, healthy subjects or affected by systemic diseases effect on the disease, statistically significance). For each paper, the following data were searched and recorded when available: a) publication year and study duration; b) details/characteristics of the participants at baseline; c) oral data, including gingival or periodontal conditions or gingival bleeding or pocket dept or gingival recession or loss of clinical attachment level; actual caries status, caries experience and caries increment measured through DMFT/S or dmft/s (for decayed, missing, filled teeth/surfaces in permanent and primary teeth indexes) or ICDAS (for International Caries Detection and Assessment System), or other detection systems; the presence of tooth wear; the presence of developmental enamel defect.

The ProMeta 3 Software (IdoStatistics <https://idostatistics.com/prometa3/>, Cesena, Italy: Internovi) was used for the meta-analysis of the data. Mean difference (MD) and odds ratio (OR) were chosen for calculating the effect size. The analysis was computed on the different vitamins used. Associations between vitamins and gingivitis, periodontitis, caries and enamel defects were computed separately. The I² statistic was calculated to describe the percentage of variation across studies due to heterogeneity rather than chance \[[@B14-ijerph-17-00938]\]. The heterogeneity was categorized as follows: \<30% not significant; 30--50% moderate; 51--75% substantial, and 76--100% considerable. Whether homogeneity was obtained or not, the random effects model (REM) with 95% confidence intervals was chosen as the meta-analysis model. Potential moderators as publication type, publication year, age groups, vitamins were evaluated and analysed to explain which factors might affect heterogeneity. The funnel plot method was used to assess the potential role of publication bias \[[@B15-ijerph-17-00938]\]. The significance levels of the effect sizes were determined based on the two-tailed test. In all tests, the level of significance was set at *p* \< 0.05.

2.6. Assessment of Bias across Studies {#sec2dot6-ijerph-17-00938}
--------------------------------------

The risk of bias assessment was conducted by two authors (C.T., T.G.W.). The methodological quality of the included RCTs was scored according to the customized quality assessment tool developed by the National Heart, Lung, and Blood Institute and Research Triangle Institute International for Observational Cohort and Cross-Sectional Studies and Study Quality Assessment Tools Guidance for Assessing the Quality of Controlled Intervention Studies [www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools](www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools) \[<https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools>\]. The tools included items for evaluating potential flaws in study methods or implementation, including sources of bias (e.g., patient selection, performance, attrition, and detection), confounding, study power, the strength of causality in the association between interventions and outcomes and other factors. For each item, "yes," "no," or "cannot determine/not reported/not applicable" was selected. Each study was finally scored as "good" when it has the least risk of bias, "fair" if it is susceptible to some bias and \"poor\" when significant risk of bias is conceivable.

Disagreements between authors were resolved by discussion. Where this was not possible, another author was consulted (M.G.C.).

3. Results {#sec3-ijerph-17-00938}
==========

The search identified 1597 papers; 741 were selected after removing duplicates. A total of 334 articles were excluded after title and abstract evaluation; 407 were assessed and 73 papers were full-text assessed ([Table S1](#app1-ijerph-17-00938){ref-type="app"}. List of excluded papers); the quality assessment scores of the papers included is presented in the [Supplementary Materials (Table S2. Quality assessment)](#app1-ijerph-17-00938){ref-type="app"}, other 14 papers were discharged after full text evaluation ([Table S3](#app1-ijerph-17-00938){ref-type="app"}. List of excluded papers after full text evaluation), leaving 58 included papers ([Figure 1](#ijerph-17-00938-f001){ref-type="fig"}).

Forty papers concerned on gingival/periodontal disease and 20 (two papers were in common) on hard dental pathological processes were included. Regarding gingival/periodontal disease, 26 papers were ranked of as being of good quality, 12 were classified of fair quality and only two of poor quality. Regarding hard dental tissues, 16 papers were ranked of as being of good quality, four were classified of fair quality and only two of poor quality ([Table 1](#ijerph-17-00938-t001){ref-type="table"}).

Funnel plot analysis ([Figure 2](#ijerph-17-00938-f002){ref-type="fig"}) showed that for gingivitis, caries and enamel defects no study was trimmed, and the overall effect sizes observed and estimated were the same 0.81, (95% CI ranging from 0.33 to 1.29; *p* = 0.06) and 1.04, (95% CI ranging from 0.92 to 1.18; *p* = 0.52) and 0.27 (95% CI ranging from −0.04 to 0.57; *p* = 0.09) respectively. Furthermore, no significant publication bias existed based on the Egger regression analysis (*p* = 0.109, 0.79 and 0.19, respectively). Regarding periodontal disease, six studies were trimmed, the observed effect size was 0.97, (95% CI ranging from 0.78 to 1.219; *p* = 0.78) while the estimated one was 0.76, (95% CI ranging from 0.60 to 0.97; *p* = 0.03) with no statistically significant publication bias (*p* = 0.91).

Due to the low numbers of studies for each vitamin, the heterogeneity was very high for all vitamins ranging from 83.68% for vitamin B to 99.13% for vitamin C ([Figure 3](#ijerph-17-00938-f003){ref-type="fig"}). Regarding gingivitis, the heterogeneity analysis was measured as considerable with the highest value observed for vitamin C. Heterogeneity analysis for periodontal disease revealed the highest value for vitamin B (97.39%) followed by vitamin D (84.39%) and then vitamin C (13.27%). Heterogeneity analysis for caries showed the highest value for vitamin C (95.50%) while a substantial I^2^ value was observed for vitamin D (70.06%). Considering enamel defects, there were not enough data levels for performing this analysis.

3.1. Gingival/Periodontal Disease {#sec3dot1-ijerph-17-00938}
---------------------------------

The main characteristics of the included studies regarding gingivitis and periodontitis/tooth loss are reported in [Table 2](#ijerph-17-00938-t002){ref-type="table"}.

Four studies were conducted to evaluate the effect of vitamin D on gingivitis; in one study vitamin D was given alone \[[@B30-ijerph-17-00938]\], while in the other three it was administered in combination with vitamin C \[[@B23-ijerph-17-00938]\] or vitamin B and E \[[@B18-ijerph-17-00938]\] or vitamin A, B1, B2, B6, B9, C, E \[[@B38-ijerph-17-00938]\] through the diet. A dose-dependent effect was found on gingival scores, showing the supplementation of 2000 International Unit (IU) of vitamin D obtained a greater improvement in gingival parameters compared to lower amount (1000 IU and 500 IU). A similar effect was obtained with a 4-week diet rich in vitamin C, D, Omega-3 fatty acids and antioxidants. All inflammatory parameters (gingival index, bleeding on probing and the total periodontal inflamed surface area) were halved compared to baseline. The administration of a dietary supplement containing different micronutrients (including vitamin D, C, E, B complex) for 3 months produced a slight improvement of the gingival inflammation in students under stress with poor oral hygiene, compared to students also under stress but not provided with the dietary supplement. The 6-month administration of a dietary supplement containing vitamin A, B1, B2, B6, B9, C, D, E in Type 2 diabetic adults, reduced gingivitis and oral ulcers incidence compared to placebo (*p* \< 0.05).

Five studies analyzed the effect of vitamin C on gingival parameters, three of them considering vitamin C as the only variable \[[@B24-ijerph-17-00938],[@B29-ijerph-17-00938],[@B49-ijerph-17-00938]\] and two on vitamin C combined with other vitamins \[[@B41-ijerph-17-00938],[@B55-ijerph-17-00938]\]. All these studies used different administration modalities, including toothpaste, dietary supplement, chewing gum and foods. In the first three studies, vitamin C showed to reduce gingival scores of inflammation. vitamin C and B9 levels were statistically associated to bleeding on probing (*p* \< 0.01) \[[@B41-ijerph-17-00938]\]; vitamin A was also associated (*p* \< 0.05), while vitamin B1 and B2 levels were found to be associated to gingivitis presence in adolescent girls, while vitamin A and B3 resulted in not being associated \[[@B55-ijerph-17-00938]\]. Three studies investigated the effects of vitamin B9 on gingival scores, two with the vitamin as the only variable \[[@B30-ijerph-17-00938],[@B34-ijerph-17-00938]\] and one with vitamin B9 combined with vitamin B12 \[[@B48-ijerph-17-00938]\]. Vitamin B9 was administered in patients with epilepsy to reduced Phenytoin-induced gingival overgrowth (PIGO) \[[@B23-ijerph-17-00938],[@B24-ijerph-17-00938],[@B29-ijerph-17-00938],[@B30-ijerph-17-00938],[@B34-ijerph-17-00938],[@B38-ijerph-17-00938],[@B39-ijerph-17-00938],[@B41-ijerph-17-00938],[@B49-ijerph-17-00938],[@B55-ijerph-17-00938]\]. In both studies vitamin B9 administration reduced the development of PIGO or delayed its onset. A statistically significantly association between vitamin B9 and gingival index was found in smokers (*p* \< 0.01) compared to non-smokers, while vitamin B12 resulted not associated \[[@B48-ijerph-17-00938]\]. Finally, a fluoridated toothpaste containing vitamin B3 and pro-vitamin B5 provided a statistically significantly reduction in calculus presence compared to a fluoridated toothpaste not containing vitamins (*p* = 0.01) \[[@B43-ijerph-17-00938]\].

Twelve papers were concerned on the effect of vitamin D on periodontitis. A reduction of the clinical disease level (i.e., clinical attachment level and/or probing pocket depth) was described in five papers \[[@B17-ijerph-17-00938],[@B19-ijerph-17-00938],[@B23-ijerph-17-00938],[@B45-ijerph-17-00938],[@B52-ijerph-17-00938]\], while in four papers \[[@B20-ijerph-17-00938],[@B25-ijerph-17-00938],[@B33-ijerph-17-00938],[@B35-ijerph-17-00938]\] vitamin D levels had no statistically significant impact on clinical attachment level and probing pocket depth improvements in teriparatide patients. Low serum vitamin D levels were not statistically associated to periodontitis and tooth loss in pregnant and post-menopausal women \[[@B22-ijerph-17-00938],[@B32-ijerph-17-00938],[@B36-ijerph-17-00938]\].

Four papers concerned on the effect of vitamin C on periodontitis. Two papers \[[@B29-ijerph-17-00938],[@B51-ijerph-17-00938]\] underlined the reduction of gingival bleeding consequent to use of vitamin C in patients affected by chronic periodontitis. The use of fruit or vegetables rich in vitamin C was statistically significantly lower in subjects affected by chronic periodontitis respect to healthy subjects \[[@B52-ijerph-17-00938]\]. Serum concentrations of vitamin C, bilirubin, and total antioxidant capacity were inversely associated with periodontitis, the association being stronger in severe disease \[[@B46-ijerph-17-00938]\]. Vitamin B-complex supplement resulted in statistically significantly superior clinical attachment gains and reduction of inflammatory mediators respect to placebo \[[@B39-ijerph-17-00938],[@B50-ijerph-17-00938]\]. The use of a standard multivitamin formula provided modest benefits in reducing periodontal inflammation \[[@B37-ijerph-17-00938]\].

Four studies reported on gingivitis/periodontitis/tooth loss and vitamin D during particular periods of a woman's life, pregnancy \[[@B21-ijerph-17-00938],[@B36-ijerph-17-00938]\], menopause \[[@B22-ijerph-17-00938],[@B32-ijerph-17-00938]\]. Low vitamin D levels in saliva and serum were statistically associated with gingivitis and periodontitis during pregnancy \[[@B21-ijerph-17-00938],[@B36-ijerph-17-00938]\]. vitamin D in post-menopausal was statistically associated with periodontitis \[[@B32-ijerph-17-00938]\], but the association with tooth loss failed \[[@B22-ijerph-17-00938],[@B32-ijerph-17-00938]\].

3.2. Hard Dental Pathological Processes {#sec3dot2-ijerph-17-00938}
---------------------------------------

The main characteristics of the studies included regarding hard tooth tissues (caries and enamel defects) are reported in [Table 3](#ijerph-17-00938-t003){ref-type="table"}.

Eleven papers were focused on vitamin D and caries; six of them \[[@B10-ijerph-17-00938],[@B22-ijerph-17-00938],[@B57-ijerph-17-00938],[@B58-ijerph-17-00938],[@B68-ijerph-17-00938]\] were observational studies showing a statistically significantly association between vitamin D serum level and caries level and/or experience. Five papers \[[@B10-ijerph-17-00938],[@B57-ijerph-17-00938],[@B58-ijerph-17-00938],[@B68-ijerph-17-00938]\] were on children (age range 1--11 years).

Vitamin D treatment in children or in mothers during pregnancy were associated to caries incidence or experience in five papers \[[@B60-ijerph-17-00938],[@B61-ijerph-17-00938],[@B64-ijerph-17-00938],[@B65-ijerph-17-00938],[@B66-ijerph-17-00938]\]. Two cross-sectional studies \[[@B67-ijerph-17-00938],[@B71-ijerph-17-00938]\] were done associating vitamin C intake and caries (levels and experience) and erosion in children. Multivitamins intake was related to caries in two papers \[[@B67-ijerph-17-00938],[@B70-ijerph-17-00938]\]; vitamin B2, B7, B12 were associated to caries \[[@B67-ijerph-17-00938]\], while vitamin A was not statistically significantly correlated and vitamin C and vitamin E. statistically significantly correlated to caries \[[@B70-ijerph-17-00938]\]. In early childhood (up to 8 years), serum levels of vitamin D seem to be associated with DMFT and caries risk in the following years \[[@B10-ijerph-17-00938],[@B58-ijerph-17-00938],[@B63-ijerph-17-00938]\]. In early teenagers (10--11 years old) a significantly less caries experience of the first molars was found, when serum vitamin D levels are higher than 50 nmol \[[@B57-ijerph-17-00938]\]. Another study found a direct correlation of serum vitamin D levels in children, 6--17 years of age. The authors found a drop in DMFT of 0.66 at each 10 ng/ml increase of vitamin D \[[@B60-ijerph-17-00938]\]. Regarding the correlation of vitamin C and the occurrence of caries lesions there are controversial results. One study found vitamin C supplementation, but also soft drink consumption, to be positively correlated to caries in 12-year-old children \[[@B67-ijerph-17-00938]\]. Another study including 6- to 13-year-old children found negative correlations between vitamins C and E and caries risk. Salivary vitamin A levels are not to be statistically significantly associated to caries risk \[[@B56-ijerph-17-00938]\]. High intake of especially vitamin B12, riboflavin, pantothenic acid and nicotinic acid seem to be correlated to lower caries rates in 5 years old children, but the association seems not clinically significant \[[@B70-ijerph-17-00938]\].

Despite caries, the occurrence of enamel hypoplasia seems to be associated with low blood levels of vitamin D during pregnancy \[[@B62-ijerph-17-00938]\], whereas the occurrence of MIH seems not affected by fetal, postnatal and early childhood levels of vitamin D \[[@B59-ijerph-17-00938]\]. One study found no association between the occurrence of enamel defects and vitamin D in 1- and 2-year-old children born preterm \[[@B72-ijerph-17-00938]\].

Newly erupted permanent teeth of children have immature enamel, which is more susceptible to acid attack of nutritional acids, e.g. soft drinks or fruit juices. The intake of vitamin C supplements was found to be associated with the incidence of erosive tooth wear in early childhood. In 2- to 5-year-old children, vitamin C supplementation significantly reduced the incidence of erosive tooth wear \[[@B71-ijerph-17-00938]\]. A study on 10- to 12-year-old children found that an intake of vitamin supplements (not specified) seems not to affect the incidence of erosive tooth wear, but decreased their progression significantly \[[@B69-ijerph-17-00938]\]. In general, malnutrition and associated deficiency in vitamin intake increases the occurrence of enamel hypoplasia in children \[[@B70-ijerph-17-00938]\].

4. Discussion {#sec4-ijerph-17-00938}
=============

There is no clear scientific evidence on the role played by vitamins on oral health. There is a general consensus on the effect of vitamins deficiencies or supplementation on oral health but without a substantial scientific evidence.

The aim of this systematic and metanalysis review was to evaluate if there were associations between vitamin intake (supplementation or diet intake or saliva/serum level) and gingival/periodontitis and hard dental pathological processes (dental caries, tooth wear and enamel defects).

The lack of convincing associations and the relative dearth of possible associations suggest that the evidence for oral health benefits of vitamins that may be reaped from population-wide vitamin supplementation is weak. The issues to attain positive outcomes from experimental clinical trials are linked to the dosages of vitamins or more effective treatments that might act as confounding factors, thereby camouflaging the effect of the vitamins. Probable associations, where highly significant effects appear in randomised trials, hold the most promise for clinical translation; however, studies pertain to specific populations (children, pregnant women, patients with systemic diseases), and even in these cases the evidence is not sufficient to make universal recommendations about daily intake. Multivitamin supplement or a combination of two or more vitamins adds more biases as it is not possible to identify the single benefit of each vitamin.

Moreover, the majority of papers are short-term papers. Hence, it was not possible to provide clear scientific evidence for the role played by vitamins. Concerning observational studies, there was a wide variety in the use of dietary supplement and clinical parameters used, which could explain the differences found among their results.

Until at least the middle of the 18th century, several oral diseases like periodontitis were considered a manifestation of vitamin deficiency \[[@B1-ijerph-17-00938],[@B8-ijerph-17-00938],[@B73-ijerph-17-00938]\], but there is no sufficient data supporting the need for vitamin supplementation for oral health. Vitamin D has been related to gingival inflammation \[[@B47-ijerph-17-00938]\] and tooth loss \[[@B17-ijerph-17-00938],[@B19-ijerph-17-00938],[@B20-ijerph-17-00938],[@B25-ijerph-17-00938],[@B33-ijerph-17-00938],[@B35-ijerph-17-00938],[@B36-ijerph-17-00938]\]. Moreover, vitamins and in particular vitamin D as a promising oral health-preventive agent were the object of several previous reviews \[[@B73-ijerph-17-00938],[@B74-ijerph-17-00938],[@B75-ijerph-17-00938],[@B76-ijerph-17-00938],[@B77-ijerph-17-00938]\], systematic \[[@B74-ijerph-17-00938],[@B75-ijerph-17-00938],[@B76-ijerph-17-00938]\] and narrative \[[@B73-ijerph-17-00938],[@B77-ijerph-17-00938]\] leading to a low-certainty conclusion that vitamins may reduce the incidence of caries and periodontitis.

5. Conclusions {#sec5-ijerph-17-00938}
==============

In general, although the existing literature suggests that vitamins are important in the prevention and treatment of oral diseases, there is weak evidence supporting the association between vitamins and both gingival/periodontal disease and hard dental pathological processes.

Overall, future longitudinal studies of the oral outcomes associated with vitamins and focused research on the detailed biological mechanisms will have broader applications in dentistry and medicine.

The following are available online at <https://www.mdpi.com/1660-4601/17/3/938/s1>: Table S1: List of excluded papers, Table S2: Quality Assessment, Table S3: List of excluded papers after full text evaluation.
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ijerph-17-00938-t001_Table 1

###### 

General characteristics of the studies included: (**a**) Gingivitis and periodontitis; (**b**) Hard dental tissues (dental caries, enamel defects).

  Author                                              Sources                                                   Type of Study   Vitamins                          Oral Conditions                   Quality Assessment
  --------------------------------------------------- --------------------------------------------------------- --------------- --------------------------------- --------------------------------- --------------------
  Li et al., \[[@B16-ijerph-17-00938]\]               Clin. Implant. Dent. Relat. Res. 2018, 20, 793--98        CT              Vit. C                            Periodontitis                     Good
  Balci Yuce et al., \[[@B17-ijerph-17-00938]\]       J. Oral. Sci. 2017, 59,:397--404                          CT              Vit. D                            Periodontitis                     Good
  Deepti et al., \[[@B18-ijerph-17-00938]\]           J. Periodontol. 2017, 88, 999--1011                       RCT             Vit. B7                           Gingivitis/Periodontitis          Good
  Abreu et al. \[[@B19-ijerph-17-00938]\]             BMC Oral Health 2016, 16, 89                              CCS             Vit. D                            Periodontitis                     Fair
  Adegboye et al., \[[@B20-ijerph-17-00938]\]         Public Health Nutr. 2016, 19, 503--51                     CSS             Vit. D                            Periodontitis                     Good
  Gümüş et al., \[[@B21-ijerph-17-00938]\]            Arch. Or. Biol. 2016, 63, 1--6                            CS              Vit. D                            Periodontitis                     Good
  Pavlesen et al., \[[@B22-ijerph-17-00938]\]         J. Periodontol 2016; 87, 852--63                          RCS             Vit. D                            Periodontitis/Tooth loss/Caries   Good
  Woelber et al., \[[@B23-ijerph-17-00938]\]          BMC Oral Health 2016, 17, 28                              RCT             Vit. C, D                         Gingivitis/Periodontitis          Good
  Shimabukuro et al., \[[@B24-ijerph-17-00938]\]      J. Periodontol 2015, 86, 27--35                           RCT             Vit. C                            Gingivitis                        Good
  Lee et al., \[[@B25-ijerph-17-00938]\]              Comm Dent. Oral Ep. 2015, 43, 471--8                      CSS             Vit. D                            Periodontitis                     Good
  Singh et al., \[[@B26-ijerph-17-00938]\]            J. Periodontol 2014, 85, 242--9                           RCT             Vit. E                            Periodontitis                     Good
  Jimenez et al., \[[@B27-ijerph-17-00938]\]          Public Health Nutr. 2014, 17, 844--52                     CSS             Vit. D                            Periodontitis/Tooth loss          Good
  Alshouibi et al., \[[@B28-ijerph-17-00938]\]        J. Dent. Res. 2013, 92, 689--93                           CSS             Vit. D                            Periodontitis                     Good
  Gokhale et al., \[[@B29-ijerph-17-00938]\]          J. Diet. Suppl. 2013, 10, 93--104.                        RCT             Vit. C                            Periodontitis                     Fair
  Hiremath et al., \[[@B30-ijerph-17-00938]\]         Oral Health Prev. Dent. 2013, 11, 61--9                   RCT             Vit. D                            Gingivitis                        Good
  Iwasaki et al., \[[@B31-ijerph-17-00938]\]          Public Health Nutr 2013, 16, 330--38                      RCS             Vit. A, D E, B6, B9, B12          Tooth loss                        Good
  Millen et al., \[[@B32-ijerph-17-00938]\]           J. Periodontol 2013, 84, 1243--56                         CSS             Vit. D                            Periodontitis                     Good
  Teles e t al., \[[@B33-ijerph-17-00938]\]           J. Periodontol 2012, 83, 1183--91                         CSS             Vit. D                            Periodontitis                     Fair
  Arya et al., \[[@B34-ijerph-17-00938]\]             Neurology 2011, 76,1338--43                               RCT             Vit. B9                           Gingivitis                        Fair
  Bashutski et al., \[[@B35-ijerph-17-00938]\]        J. Dent. Res. 2011, 90, 1007--12                          RCT             Vit. D                            Periodontitis                     Good
  Boggess et al., \[[@B36-ijerph-17-00938]\]          J. Periodontol 2011, 82, 195--200                         CCS             Vit. D                            Periodontitis                     Good
  Harpenau et al., \[[@B37-ijerph-17-00938]\]         J. Calif. Dent. Assoc. 2011, 39, 309--18                  CT              Vit A, C, E, B6, B9, B12          Gingivitis                        Poor
  Liu et al., \[[@B38-ijerph-17-00938]\]              Asia Pac. J. Clin. Nutr., 2011, 20, 375--82               RCT             Vit. A, B1, B2, B6, B9, C, D, E   Gingivitis                        Fair
  Willershausen et al., \[[@B39-ijerph-17-00938]\]    Eur. J. Med. Res. 2011, 16, 514--18                       CSS             Vit. B complex, C, D, E           Gingivitis                        Fair
  Abou Sulaiman, et al., \[[@B40-ijerph-17-00938]\]   J. Periodontol 2010, 81, 1547--54                         RCT             Vit. C                            Periodontitis                     Fair
  Esaki et al., \[[@B41-ijerph-17-00938]\]            Oral Disease 2010, 16,96--101                             CSS             Vit. A, B1, B2 B9, C              Gingivitis                        Good
  Liu, et al., \[[@B42-ijerph-17-00938]\]             J. Periodontol 2009, 80, 1114--20                         CT              Vit. D                            Periodontitis                     Fair
  Llena et al., \[[@B43-ijerph-17-00938]\]            Quintessence Int. 2009, 40, 497--501                      CT              Vit. B3, pro-vitamin B5           Gingivitis                        Poor
  Linden et al., \[[@B44-ijerph-17-00938]\]           J. Clin Periodontol. 2009, 36, 843--4                     CSS             Vit. A                            Periodontitis                     Good
  Miley et al., \[[@B45-ijerph-17-00938]\]            J. Periodontol. 2009, 80, 1433--39                        CSS             Vit. D                            Periodontitis                     Good
  Chapple, et al., \[[@B46-ijerph-17-00938]\]         J. Nutr. 2007, 137, 657--64                               CSS             Vit. A, C, E                      Periodontitis                     Good
  Dietrich et al., \[[@B47-ijerph-17-00938]\]         J. Dent. Res 2006, 85, 1134--37                           CSS             Vit. C                            Periodontitis                     Good
  Erdemir & Bergstrom \[[@B48-ijerph-17-00938]\]      J. Clin. Periodontol. 2006, 33, 878--84                   CSS             Vit B9, B12                       Periodontitis                     Good
  Lingstrom et al., \[[@B49-ijerph-17-00938]\]        Eur. J. Oral Sci. 2005, 113, 20--27                       CT              Vit. C                            Gingivitis                        Good
  Neiva et al., \[[@B50-ijerph-17-00938]\]            J. Periodontol 2005, 76, 1084--91                         RCT             Vit. B complex                    Periodontitis                     Fair
  Staudte et al., \[[@B51-ijerph-17-00938]\]          Br. Dent. J. 2005, 199, 213--7                            CT              Vit. C                            Gingivitis                        Fair
  Dietrich et al., \[[@B52-ijerph-17-00938]\]         Am. J. Clin. Nutr. 2004, 80, 108--13                      CSS             Vit. D                            Periodontitis                     Good
  Prasad et al., \[[@B53-ijerph-17-00938]\]           J. Indian Soc. Pedo Prev. Dent. 2004 22, 82--91           CT              Vit. B9                           Gingivitis                        Fair
  Krall et al., \[[@B54-ijerph-17-00938]\]            Am. J. Med. 2001, 111, 452-456                            RCT             Vit. D                            Tooth loss                        Good
  Petti et al., \[[@B55-ijerph-17-00938]\]            Community Dent. Oral Epidemiol. 2000, 28, 407--413        CCS             Vit. A, B1, B2, B3, C             Gingivitis/Caries                 Fair
  (**a**)                                                                                                                                                                                           
  Syed et al., \[[@B56-ijerph-17-00938]\]             *BioMed. Res. Int.***2019**, 4503450                      CSS             Vit. A, C, E                      Caries                            Poor
  Gyll et al., \[[@B10-ijerph-17-00938]\]             *Nutr. J.***2018***, 17*, 11                              CSS             Vit. D                            Caries                            Good
  Kim et al., \[[@B57-ijerph-17-00938]\]              *BMC Oral Health***2018**, *18*, 43                       CSS             Vit. D                            Caries                            Good
  Seminario et al., \[[@B58-ijerph-17-00938]\]        *J. Dent. Child***2018**, *3*, 93--101                    CSS             Vit. D                            Caries                            Good
  van der Tas et al., \[[@B59-ijerph-17-00938]\]      *Community Dent. Oral Epidemiol.***2018**, *46*, 343-51   CS              Vit. D                            Enamel defects                    Good
  Wójcik et al., \[[@B60-ijerph-17-00938]\]           *Medicine***2018**, *97*, 8(e9811)                        CSS             Vit. D                            Caries                            Poor
  Kühnisch et al., \[[@B61-ijerph-17-00938]\]         *Clin. Oral Invest.***2017**, *21*, 2283--2290            RCS             Vit. D                            Caries                            Good
  Reed et al., \[[@B62-ijerph-17-00938]\]             *Ped. Dent. J.***2017**, *27*, 21e28                      PiS             Vit. D                            Enamel defects                    Good
  Pavlesen et al., \[[@B22-ijerph-17-00938]\]         *J Periodontol***2016**; 87, 852--63                      CSS/PS          Vit. D                            Periodontitis/Tooth loss/Caries   Good
  Dudding et al., \[[@B63-ijerph-17-00938]\]          *PLoS One***2015**, 10, e0143769                          MRS             Vit. D                            Caries                            Good
  Kühnisch et al., \[[@B64-ijerph-17-00938]\]         *J. Dent. Res.***2015**, 94, 381--87                      CSS             Vit. D                            Enamel Defects                    Good
  Tanaka et al., \[[@B65-ijerph-17-00938]\]           *Annals of Epidemiology***2015**, *25*, 620e625           PSA             Vit. D                            Caries                            Good
  Schroth et al., \[[@B66-ijerph-17-00938]\]          *Ped.***2014**, 133, e1277-e1284                          RCS             Vit D                             Caries                            Fair
  Zhang et al., \[[@B67-ijerph-17-00938]\]            *BMC Pub. Health***2014**, 14,7                           CSS             Vit. C                            Caries/Erosion                    Fair
  Schroth et al., \[[@B68-ijerph-17-00938]\]          *BMC Pediatrics***2013**, 13:174                          CCS             Vit. D                            Caries                            Good
  El Aidi et al., \[[@B69-ijerph-17-00938]\]          *Caries Res***2011**, 45, 303--312                        PS              vitamins (unspecified)            Erosion                           Good
  MacKeown et al., \[[@B70-ijerph-17-00938]\]         *Community Dent Oral Epidemiol***2003**, *31*, 213--20    CSS             Vit. A, B complex, C, D           Caries                            Good
  Al Malik et al., \[[@B71-ijerph-17-00938]\]         *Int. J. Paed. Dent.***2001**, 11, 430--39                CSS             Vit. C                            Caries/Erosion                    Good
  Aine et al., \[[@B72-ijerph-17-00938]\]             *J Oral Pathol Med***2000**, 29, 403--9                   CCS             Vit. D                            Enamel defects                    Good
  Petti et al., \[[@B55-ijerph-17-00938]\]            *Community Dent Oral Epidemiol***2000**; 28, 407--13      CCS             Vit. B12                          Gingivitis/Caries                 Fair
  (**b**)                                                                                                                                                                                           

**CCS**: Case-control study; **CS**: Cohort Study; **CSS**: Cross-Sectional Study; **CT**: Clinical Trial, **MRS**: Mendelian Randomization Study; **PSA**: Prospective Study Analysis; **PiS**: Pilot Study **RCS**: Retrospective Cohort Study; **RCT**: Randomized Clinical Trial.
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###### 

Main characteristics of the studies included regarding gingivitis and periodontitis/tooth loss. (**a**) Gingivitis, (**b**) Periodontitis, (**c**) Tooth loss.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author (Year)                                              Type of Study   Location         N Subjects Age-Range   M/F   Study Length         Vitamins Administration            Study Design (Groups Treatment)                                                                                                  Physical/Pathologic Condition      Outcomes
  ---------------------------------------------------------- --------------- ---------------- ---------------------- ----- -------------------- ---------------------------------- -------------------------------------------------------------------------------------------------------------------------------- ---------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gümüş et al., (2016) \[[@B21-ijerph-17-00938]\]            CS              USA              176\                   F     \-\--                Vit. D\                            3 groups:\                                                                                                                       Pregnancy post-partum              In pregnancy and post-partum low level of Vit. D were statistically significantly associated to bleeding on probing
                                                                                              (19--40 yy)                                       \-\--                              *-pregnancy (n = 59)*\                                                                                                                                              
                                                                                                                                                                                   *-post-partum (n = 47)*\                                                                                                                                            
                                                                                                                                                                                   *-non pregnant woman (n = 70)*\                                                                                                                                     
                                                                                                                                                                                   Oral examination Vit. D in saliva                                                                                                                                   

  Shimabukuro et al., (2015) \[[@B24-ijerph-17-00938]\]      RCT             Japan            300\                   M/F   3 months             Vit. C\                            2 groups:\                                                                                                                       None                               Vit. C toothpaste statistically significantly reduced gingival inflammation (*p* \< 0.01)
                                                                                              (20--64 yy)                                       toothpaste                         *-toothpaste with Vit. C*\                                                                                                                                          
                                                                                                                                                                                   *-control toothpaste*                                                                                                                                               

  Woelber et al., (2017) \[[@B23-ijerph-17-00938]\]          RCT             Germany          15\                    M/F   8 weeks              Vit. C, D\                         2 groups:\                                                                                                                       None                               In *diet modification* group gingival parameters improved (*p* \< 0.05)
                                                                                              (23--70 yy)                                       \-\--                              -*diet modification* (n = 10)\                                                                                                                                      
                                                                                                                                                                                   -*no diet modification* (n = 5)                                                                                                                                     

  Gokhale et al., (2013) \[[@B29-ijerph-17-00938]\]          RCT             India            120\                   M/F   2 weeks              Vit. C\                            4 groups:\                                                                                                                       Type 2 diabetes                    A statistically significantly reduction in the bleeding score in the following groups that received Vit. C:\
                                                                                              (30--60 yy)                                       \-\--                              -*healthy subjects*\                                                                                                                                                *-chronic gingivitis*\
                                                                                                                                                                                   *-chronic gingivitis*\                                                                                                                                              *-chronic periodontitis and type 2 diabetes*
                                                                                                                                                                                   *-chronic periodontitis*\                                                                                                                                           
                                                                                                                                                                                   *-chronic periodontitis and type 2 diabetes*\                                                                                                                       
                                                                                                                                                                                   Scaling and root planing with or without vit. C supplementation (450 mg)                                                                                            

  Hiremath et al., (2013) \[[@B30-ijerph-17-00938]\]         RCT             India            110\                   M/F   3 months             Vit. D\                            4 groups:\                                                                                                                       None                               Gingivitis scores improved:\
                                                                                              (18--64 yy)                                       tablets                            *-2000 UI Vit. D*\                                                                                                                                                  *-2000 UI Vit. D*: 2.4 at baseline to 0.3 at 3mo.\
                                                                                                                                                                                   *-1000 UI Vit. D*\                                                                                                                                                  *-1000 UI Vit. D*: 2.3 at baseline to 0.5 at 3 mo.\
                                                                                                                                                                                   *-500 UI Vit. D*\                                                                                                                                                   *-500 UI Vit.* *D:* 2.2 at baseline to 0.8 at 3 mo.\
                                                                                                                                                                                   *-placebo*                                                                                                                                                          *-placebo:* 2.2 at baseline to 1.8 at 3 mo.

  Arya et al., (2011) \[[@B34-ijerph-17-00938]\]             RCT             India            120\                   M/F   6 months             Vit. B9\                           2 groups:\                                                                                                                       Epilepsy                           *Vit. B9* group 21% developed PIGO\
                                                                                              (6--15 yy)                                        tablets                            *-Vit. B9 (5mg/die) (n = 62)*\                                                                                                                                      *Placebo* group 88% developed PIGO
                                                                                                                                                                                   *-placebo (n = 68)*\                                                                                                                                                
                                                                                                                                                                                   Oral examination                                                                                                                                                    

  Liu et al., (2011) \[[@B38-ijerph-17-00938]\]              RCT             China            196\                   M/F   6 months             Vit. A, B1, B2, B6, B9, C, D, E\   2 groups:\                                                                                                                       Type 2 diabetes                    Gingivitis and oral ulcer incidences were lower in *multivitamin formula* group (*p* \< 0.05)
                                                                                              (54--72 yy)                                       \-\--                              -*multivitamin formula (n = 97)*\                                                                                                                                   
                                                                                                                                                                                   *-placebo (n = 99)*                                                                                                                                                 

  Willershausen et al., (2011) \[[@B39-ijerph-17-00938]\]    CSS             Germany          40\                    M/F   3 months             Vit. B complex, C, D, E\           2 groups:\                                                                                                                       None                               A slight improvement of gingival inflammation in *micronutrients* group.
                                                                                              (24--30 yy)                                       \-\--                              -*multivitamin formula (n = 19)*\                                                                                                                                   
                                                                                                                                                                                   *-no treatment (n = 21)*\                                                                                                                                           
                                                                                                                                                                                   Oral examination, dietary questionnaire, microbiology and blood analysis                                                                                            

  Esaki et al., (2010) \[[@B41-ijerph-17-00938]\]            CSS             Japan            497\                   M/F   \-\--                Vit. A, B1, B2, B9, C\             Oral examination\                                                                                                                None                               Higher bleeding on probing scores statistically significantly associated to lower levels of Vit. C and Vit. B9 (*p* \< 0.01) and Vit. A (*p* \< 0.05)
                                                                                              (\-\--)                                           \-\--                              Dietary questionnaire                                                                                                                                               

  Llena et al., (2009) \[[@B43-ijerph-17-00938]\]            CT              Spain            4\                     M/F   3 months +3 months   Vit. B3, Pro-vit. B5\              2 groups (cross-over design):\                                                                                                   None                               Fluoridated toothpaste with Vit. B3/Provit. B5 provided a statistically significant reduction in calculus presence (*p* = 0.01)
                                                                                              8(20--34 yy)                                      toothpaste                         -*fluoridated toothpaste*\                                                                                                                                          
                                                                                                                                                                                   -*fluoridated toothpaste with Vit. B3/Provit.* *B5,*\                                                                                                               
                                                                                                                                                                                   Oral examination/calculus presence                                                                                                                                  

  Erdemir &Bergstrom, (2006) \[[@B48-ijerph-17-00938]\]      CSS             Sweden           88(30--69 yy)          M/F   \-\--                Vit. B9, B12\                      2 groups:\                                                                                                                       None                               In smokers higher gingival index scores and lower Vit. B9 levels (*p* \< 0.05 for both)
                                                                                                                                                \-\--                              *-current smokers (n = 45)*\                                                                                                                                        
                                                                                                                                                                                   *-non smokers (n = 43)*\                                                                                                                                            
                                                                                                                                                                                   Oral examination/Vit. B9, B12 serum level                                                                                                                           

  Lingstrom et al., (2005) \[[@B49-ijerph-17-00938]\]        CT              Sweden           30\                    M/F   3 months             Vit. C\                            2 groups:\                                                                                                                       None                               A significant reduction in the total calculus score after the use of Vit. C (33%) and Vit. C + carbamide (12%) gums compared with no gum use
                                                                                              (\-\--)                                           gums                               *-5 pieces/day chewing gum vit. C/without vit. C, no gum use*\                                                                                                      
                                                                                                                                                                                   *-10 pieces/day chewing gum with vit.* *C+ carbamide (30 mg + 30 mg), no gum use*\                                                                                  
                                                                                                                                                                                   Calculus score/plaque/gingivitis                                                                                                                                    

  Prasad et al., (2004) \[[@B53-ijerph-17-00938]\]           CT              India            60\                    M/F   1 year               Vit. B9\                           2 groups:\                                                                                                                       Epilepsy treated with phenytoin    Gingival overgrowth: 60% in *oral hygiene instruction alone* and 50% in *Vit. B9 and oral hygiene instruction*. Delay in onset of overgrowth in *Vit. B9 and oral hygiene instruction*
                                                                                              (8--13 yy)                                        tablets                            *-Vit. B9 (5mg/die) and oral hygiene instruction*\                                                                                                                  
                                                                                                                                                                                   *-oral hygiene instructions alone*\                                                                                                                                 
                                                                                                                                                                                   Oral examination                                                                                                                                                    

  Petti et al., (2000) \[[@B55-ijerph-17-00938]\]            CCS             Italy            54\                    F     \-\--                Vit. A, B1, B2, B3, C\             2 groups:\                                                                                                                       None                               Vit. B1 and Vit. B2 levels statistically lower in subjects with gingivitis presence
                                                                                              (17--19 yy)                                       \-\--                              -*gingivitis affected*\                                                                                                                                             
                                                                                                                                                                                   *-no gingivitis affected*\                                                                                                                                          
                                                                                                                                                                                   Oral examination/ three-day food record                                                                                                                             

  (**a**)                                                                                                                                                                                                                                                                                                                                              

  Balci Yuce et al., (2017) \[[@B17-ijerph-17-00938]\]       CT              Turkey           53\                    M/F   6 weeks              Vit. D\                            3 groups:\                                                                                                                       Rheumatoid arthritis               Periodontal parameters statistically significantly improved in all groups\
                                                                                              (37--61 yy)                                       \-\--                              -*rheumatoid arthritis/periodontitis (RP)*\                                                                                                                         Vit. D was higher in *RP* and *P* than in *H* group and decreased in RP group after treatment
                                                                                                                                                                                   *-periodontitis (P)*\                                                                                                                                               
                                                                                                                                                                                   *-healthy (H)*\                                                                                                                                                     
                                                                                                                                                                                   Treatment: initial periodontal treatment                                                                                                                            

  Deepti et al., (2017) \[[@B18-ijerph-17-00938]\]           RCT             India            60\                    F     3-6 months           Vit. B7\                           2 groups:\                                                                                                                       Polycystic ovary syndrome (PCOS)   In *scaling-root planing+Vit. B7* group a statistically significantly reduction of C-reactive protein and insulin resistance at 3-6 mo. was found. Periodontal parameters also improved at 3-6 mo.
                                                                                              (15--34 yy)                                       \-\--                              *- scaling-root planing+Vit. B7*\                                                                                                                                   
                                                                                                                                                                                   *- Vit. B7*                                                                                                                                                         

  Abreu et al. (2016) \[[@B19-ijerph-17-00938]\]             CCS             Puerto Rico      4\                     M/F   \-\--                Vit. D\                            2 groups:\                                                                                                                       None                               Lower OR for periodontitis (OR = 0.885; 95%CI= 0.785, 0.997) for each Vit. D unit increase
                                                                                              8(35-64 yy)                                       \-\--                              -*moderate/severe periodontitis*\                                                                                                                                   
                                                                                                                                                                                   *-healthy*\                                                                                                                                                         

  Adegboye et al., (2015) \[[@B20-ijerph-17-00938]\]         CSS             Denmark          3287\                  M/F   \-\--                Vit. D\                            Dietary questionnaire\                                                                                                           None                               No association Vit. D levels between severe periodontitis presence
                                                                                              (18--95 yy)                                       \-\--                              Oral examination                                                                                                                                                    

  Lee et al., (2015) \[[@B25-ijerph-17-00938]\]              CSS             Korea            6011\                  M/F   \-\--                Vit. D\                            Vit. D level\                                                                                                                    None                               No association between Vit. D level and periodontitis\
                                                                                              (\-\--)                                           \-\--                              Oral examination (CPI index)                                                                                                                                        In smokers an association was found (OR 1.53, 95% CI 1.07--2.18)

  Singh et al., (2014 \[[@B26-ijerph-17-00938]\])            RCT             India            60\                    M/F   3 months             Vit. E\                            2 groups:\                                                                                                                       None                               Superoxide dismutase improved in both treatment groups, but was higher in *SRP+300 IU Vit. E* (*p* \< 0.05)
                                                                                              (22--50 yy)                                       tablets                            -*periodontitis (n = 38): 19 treated with scaling/root planing (SRP) and 19 with SRP+300 IU Vit. E*\                                                                
                                                                                                                                                                                   *-healthy (n = 22) no treatment*                                                                                                                                    

  Alshouibi et al. (2013) \[[@B28-ijerph-17-00938]\]         CS              USA              562\                   M     \-\--                Vit. D\                            Vit. D intake\                                                                                                                   None                               Vit. D intake ≥ 800 IU associated with lower odds of severe periodontal disease (OR = 0.67, 95% CI = 0.55-0.81)
                                                                                              (\-\--)                                           \-\--                              Oral examination (4 times during 12 yy)                                                                                                                             

  Gokhale et al., (2013) \[[@B29-ijerph-17-00938]\]          RCT             India            120\                   NA    2 weeks              Vit. C\                            4 groups\                                                                                                                        Type 2 diabetes                    Statistically significant reduction of the bleeding score in the subgroups receiving Vit. C
                                                                                              (30--60 yy)                                       \-\--                              -*healthy subjects;*\                                                                                                                                               
                                                                                                                                                                                   *-chronic gingivitis;*\                                                                                                                                             
                                                                                                                                                                                   *-chronic periodontitis,*\                                                                                                                                          
                                                                                                                                                                                   *-chronic periodontitis and type 2 diabetes*\                                                                                                                       
                                                                                                                                                                                   Scaling and root planing with or without vit. C supplementation (450 mg)                                                                                            

  Millen et al., (2013) \[[@B32-ijerph-17-00938]\]           CSS             USA              920\                   F     \-\--                Vit. D\                            *-Vit. D level*\                                                                                                                 Post-menopausa                     No association Vit. D and alveolar crestal height/ tooth loss OR = 0.96, (95%CI: 0.68--1.35). Vit. D associated to clinical attachment level and probing pocket depth (95%CI: 5--53%)
                                                                                              (50--79 yy)                                       \-\--                              *-oral examination*                                                                                                                                                 

  Teles et al., (2012 \[[@B33-ijerph-17-00938]\])            CSS             USA              56\                    M/F   6 months             Vit. D\                            Periodontal patients\                                                                                                            None                               No associations between Vit. D and clinical and microbial parameters
                                                                                              (23--71 yy)                                       \-\--                              Scaling, root planing and hygiene instruction\                                                                                                                      
                                                                                                                                                                                   Bacteria in sub-gingival plaque\                                                                                                                                    
                                                                                                                                                                                   Vit. D level                                                                                                                                                        

  Bashutski et al., (2011) \[[@B35-ijerph-17-00938]\]        RCT             USA              40\                    M/F   6 months             Vit. D\                            2 groups:\                                                                                                                       None                               Vit. D levels had no statistically significant impact on clinical attachment level and probing pocket depth improvements in teriparatide patients
                                                                                              (31--65 yy)                                       tablets                            *-periodontal surgery, Ca (1000 mg) and Vit. D (800 UI) supplements and self-administered teriparatide for 6 weeks*\                                                
                                                                                                                                                                                   - *periodontal surgery, Ca (1000 mg) and Vit. D (800 UI) supplements and placebo for 6 weeks*                                                                       

  Boggess et al., (2011) \[[@B36-ijerph-17-00938]\]          CCS             USA              233\                   F     \-\--                Vit. D\                            2 groups:\                                                                                                                       Pregnancy                          Pregnant woman with periodontitis had statistically significant lower Vit. D levels and more likely to have Vit. D insufficiency (65% *versus* 29%)
                                                                                              (21--33 yy)                                       \-\--                              -*pregnant woman with moderate to severe periodontitis*\                                                                                                            
                                                                                                                                                                                   *-pregnant woman without periodontitis*\                                                                                                                            
                                                                                                                                                                                   Vit. D level and Oral examination between 14 and 26 weeks of gestation                                                                                              

  Harpenau et al., (2011) \[[@B37-ijerph-17-00938]\]         CT              USA              89\                    M/F   8 weeks              Vit. A, C, E, B6, B9, B12\         2 groups with mild to severe periodontitis:\                                                                                     None                               Both groups showed non-significant trends for improvement in gingival, bleeding, probing depth and clinical attachment scores.
                                                                                              (18--70 yy)                                       tablets                            *-multivitamin formula*\                                                                                                                                            
                                                                                                                                                                                   *-placebo*                                                                                                                                                          

  Abou Sulaiman, et al., (2010) \[[@B40-ijerph-17-00938]\]   RCT             Syria            60\                    M/F   3 months             Vit. C\                            2 groups:\                                                                                                                       None                               The two groups showed significant reductions in all clinical measures
                                                                                              (23--65 yy)                                       tablets                            *-chronic periodontitis (n = 30)-15 subjects non-surgical treatment plus Vit. C and 15 subjects non surgical treatment alone*\                                      
                                                                                                                                                                                   *-healthy controls(n = 30)*\                                                                                                                                        

  Liu, et al., (2009) \[[@B41-ijerph-17-00938]\]             CT              China            17\                    M/F   \-\--                Vit. D\                            3 groups:\                                                                                                                       None                               In *AgP* Vit. D was higher than in *healthy controls* (29.28 vs. 21.60 nmol/l; *p* \< 0.05) and significantly correlated with bleeding index (*r* = 0.321; *p* \< 0.05).
                                                                                              8(23--41 yy)                                      \-\--                              *-aggressive periodontitis (AgP) (n = 66)*\                                                                                                                         
                                                                                                                                                                                   *-chronic periodontitis (CP) (n = 52)*\                                                                                                                             
                                                                                                                                                                                   *-healthy controls (n = 60)*\                                                                                                                                       
                                                                                                                                                                                   Oral examination/Vit. D level                                                                                                                                       

  Linden et al., (2009) \[[@B44-ijerph-17-00938]\]           CSS             United Kingdom   125\                   M     \-\--                Vit.\                              Oral examination/questionnaire                                                                                                   None                               Vit. A lower in the men with low-threshold periodontitis (*p* \< 0.001) and high-threshold periodontitis (*p* = 0.002) compared to subjects without periodontitis
                                                                                              8(60--70 yy)                                      A\-\--                                                                                                                                                                                                 

  Miley et al., (2009) \[[@B45-ijerph-17-00938]\]            CSS             USA              51\                    M/F   \-\--                Vit. D\                            2 groups:\                                                                                                                       None                               *Periodontal maintenance + Vit. D* (400 IU/day) *and Ca* (1000 mg/day) had lower but not statistically significant probing depths
                                                                                              (50--80 yy)                                       tablets                            *-periodontal maintenance + Vit. D (400 IU/day) and Ca (1,000 mg/day) (n = 23)*\                                                                                    
                                                                                                                                                                                   *-periodontal maintenance only (n = 28)*\                                                                                                                           
                                                                                                                                                                                   Oral examination                                                                                                                                                    

  Chapple, et al., (2007) \[[@B46-ijerph-17-00938]\]         CSS             USA              11,480\                M/F   \-\--                Vit. A, C, E\                      Oral examination/questionnaire/ Vit. A, C, E level                                                                               None                               Subjects with the highest values of serum Vit. C had 47% (95%CI 32, 58) lower odds of periodontitis than subjects with the lowest values (trend OR: 0.76, 95%CI 0.69, 0.84)
                                                                                              (25--70 yy)                                       \-\--                                                                                                                                                                                                  

  Dietrich et al., (2006) \[[@B47-ijerph-17-00938]\]         CSS             USA              462\                   M     \-\--                Vit. C\                            2 groups:\                                                                                                                       None                               Subjects with periodontitis had a Vit. C intake (mg) lower than subjects without periodontitis (120±201 *vs* 197±267)
                                                                                              (47--92 yy)                                       \-\--                              *-periodontitis (n = 86)*\                                                                                                                                          
                                                                                                                                                                                   *-no periodontitis (n = 376)*\                                                                                                                                      
                                                                                                                                                                                   Oral examination/Dietary questionnaire                                                                                                                              

  Neiva et al., (2005) \[[@B50-ijerph-17-00938]\]            RCT             USA              30\                    M/F   180 days             Vit. B complex\                    2 groups:\                                                                                                                       None                               Statistically significant difference between mean clinical attachment level between *periodontal surgery and Vit. B* (+0.41±0.12) and *periodontal surgery and placebo* (−0.52 ± 0.23)
                                                                                              (38--65 yy)                                       tablets                            *- periodontal surgery and Vit-B for 30 days*\                                                                                                                      
                                                                                                                                                                                   *- periodontal surgery and placebo*\                                                                                                                                
                                                                                                                                                                                   Oral examination/BANA test                                                                                                                                          

  Staudte et al., (2005) \[[@B51-ijerph-17-00938]\]          CT              Germany          80\                    M/F   2 weeks              Vit. C\                            2 groups:\                                                                                                                       None                               Bleeding index statistically significantly decreased after Grapefruit consumption
                                                                                              (22--75 yy)                                       diet                               *-healthy (n = 22)*\                                                                                                                                                
                                                                                                                                                                                   *-periodontitis: using or not grapefruit (n = 38)*\                                                                                                                 
                                                                                                                                                                                   Oral examination/Vit. C level                                                                                                                                       

  Dietrich et al., (2004) \[[@B52-ijerph-17-00938]\]         CSS             USA              11,202\                M/F   \-\--                Vit. D\                            Oral examination/Vit. D level                                                                                                    None                               Vit. D levels were statistically significantly lower in men/women \>50 years with greater periodontal attachment loss
                                                                                              (20--75 yy)                                       \-\--                                                                                                                                                                                                  

  (**b**)                                                                                                                                                                                                                                                                                                                                              

  Pavlesen et al., (2016) \[[@B22-ijerph-17-00938]\]         CSS/PS          USA              70\                    F     5 years              Vit. D\                            Oral examination\                                                                                                                Post-menopausa                     No association between Vit. D levels and history or incidence of tooth loss caused by periodontal disease
                                                                                              (53--85 yy)                                       \-\--                              Vit. D level                                                                                                                                                        

  Jimenez et al., (2014) \[[@B27-ijerph-17-00938]\]          CSS             USA              42,730\                M     \-\--                Vit. D\                            Self-reported tooth loss and periodontitis\                                                                                      None                               Men with highest levels of Vit. D exhibited a significantly lower risk of tooth loss compared with men with lowest levels
                                                                                              (40--75 yy)                                       \-\--                              Predicted Vit. D based on data on 1095 man                                                                                                                          

  Iwasaki et al., (2013) \[[@B31-ijerph-17-00938]\]          RCS             Japan            286\                   M/F   5 years              Vit. A, D E, B6, B9, B12\          Dietary questionnaire (baseline and after 5 yy)\                                                                                 None                               Subjects with impaired dentition showed a significantly greater decline in nutrients intake (Vit. A and E)
                                                                                              (75--80 yy)                                       tablets                            Oral examination (functional tooth units)                                                                                                                           

  Millen et al., (2013) \[[@B32-ijerph-17-00938]\]           CSS             USA              920\                   F     \-\--                Vit. D\                            Vit. D level\                                                                                                                    Post-menopausa                     No association between Vit. D and alveolar crestal height/ tooth loss *OR* = 0.96, (95%CI: 0.68--1.35)
                                                                                              (50--79 yy)                                       \-\--                              Oral examination                                                                                                                                                    

  (**c**)                                                                                                                                                                                                                                                                                                                                              
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**95%CI**: Confidence Intervals; **CCS**: Case-control study; **CS**: Cohort Study; **CSS**: Cross-Sectional Study; **CT**: Clinical Trial, **MRS**: Mendelian Randomization Study; **PIGO**: Phenytoin-induced gingival overgrowth; **PS**: Pilot study; **PSA**: Prospective Study Analysis; **RCS**: Retrospective Cohort Study; **RCT**: Randomized Clinical Trial; **F**: Females; **M**: Males; **OR**: Odds Ratio; **yy**: age range in years.

ijerph-17-00938-t003_Table 3

###### 

Main characteristics of the studies included regarding hard dental pathological processes ((**a**) caries and (**b**) enamel defects).

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author (Year)                                           Type of Study   Location          N Subjects Age-Range   M/F   Study Length   Vitamins Administration    Study Design (Groups Treatment)              Physical/Pathologic Condition         Outcomes
  ------------------------------------------------------- --------------- ----------------- ---------------------- ----- -------------- -------------------------- -------------------------------------------- ------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Syed et al., (2019) \[[@B56-ijerph-17-00938]\]          CSS             Saudi Arabia      100\                   M/F   \-\--          Vit. A, C, E\              Two groups:\                                 None                                  Vit. A not statistically significantly correlated\
                                                                                            (6--13 yy)                                  \-\--                      *-DMFS/dmfs=0*\                                                                    Vit. C and Vit. E. statistically significantly correlated to caries experience
                                                                                                                                                                   *-DMFS/dmfs\>3*\                                                                   
                                                                                                                                                                   Saliva samples                                                                     

  Gyll et al., (2018) \[[@B10-ijerph-17-00938]\]          CSS             Sweden            206\                   M/F   \-\--          Vit. D\                    Vit. D serum level\                          None                                  Vit. D level statistically significantly associated to caries experience (*OR* = 0.96; *p* = 0.024)
                                                                                            (8 yy)                                      \-\--                      DMFT                                                                               

  Kim et al., (2018) \[[@B57-ijerph-17-00938]\]           CSS             Korea             1688\                  M/F   \-\--          Vit. D\                    Vit. D serum level\                          None                                  *Vit. D* \< 0.25 nmol statistically significantly associated to caries experience (*p* \< 0.05)
                                                                                            (10-11 yy)                                  \-\--                      DMFT                                                                               

  Seminario et al., (2018) \[[@B58-ijerph-17-00938]\]     CSS             USA               276\                   M/F   \-\--          Vit. D\                    Vit. D serum level\                          Neurologic and genetic disabilities   Vit. D level associated to caries in neurologic (*p* \< 0.01) and genetic (*p* \< 0.01) conditions
                                                                                            (1--6 yy)                                   \-\--                      DMFT                                                                               

  Wójcik et al., (2018) \[[@B60-ijerph-17-00938]\]        CS              Poland            121\                   M/F   9 months       Vit. D\                    Human recombinant growth hormone\            Growth problems                       Caries prevalence reduced by 0.66 per each 10 ng/mL of Vit. D increase
                                                                                            (6--17 yy)                                  \-\--                      Vit. D serum level\                                                                
                                                                                                                                                                   DMFT                                                                               

  Kühnisch et al., (2017) \[[@B61-ijerph-17-00938]\]      RCS             Germany           406\                   M/F   10 yy          Vit. D\                    Vit. D supplementation\                      None                                  Vit. D + fluoride \< 6 months associated to caries *OR* = 2.47 (95%CI = 1.32--4.63)\
                                                                                            (at birth)                                  tablets                    Fluoride varnish dmfs                                                              Vit. D + fluoride \>6 mo. associated to caries *OR* = 2.08 (95%CI = 1.00--4.32)

  Pavlesen et al., (2016) \[[@B22-ijerph-17-00938]\]      CSS/PS          USA               558\                   F     5 yy           Vit. D\                    Oral examination\                            Post-menopausa                        Tooth loss due to caries associated to Vit. D *OR* = 1.03 (95%CI =0.62/1.72)
                                                                                            (53--85 yy)                                 \-\--                      Vit. D serum level                                                                 

  Dudding et al., (2015) \[[@B63-ijerph-17-00938]\]       MRS             UK                5545\                  M/F   \-\--          Vit- D\                    Vit. D serum level\                          None                                  Caries not statistically significantly associated to 10 ng/mL of Vit. D increase OR 0.93 (95%CI = 0.83-1.05)
                                                                                            (3--8 yy)                                   \-\--                      DMFT/dmft                                                                          

  Kühnisch et al., (2015) \[[@B64-ijerph-17-00938]\]      CSS             Germany           1148\                  M/F   10 yy          Vit. D\                    Vit. D supplementation\                      None                                  Vit. D statistically significantly associated to caries OR 0.90 (95%CI = 0.82--0.97) per each 10 ng/mL of Vit. D increase
                                                                                            (\--)                                       tablets                    DMFT/dmft\                                                                         
                                                                                                                                                                   MIH                                                                                

  Tanaka et al., (2015) \[[@B65-ijerph-17-00938]\]        PSA             Japan             1210 mother-child\     M/F   \-\--          Vit. D\                    Vit. D intake in pregnancy\                  None                                  OR for dmft 1.06 (95%CI = 0.72--1.56) of Vit. D during pregnancy, quartiles 2, 3\
                                                                                            (36--46 mo)                                 diet                       dmft in children                                                                   OR for dmft 0.67 (95%CI = 0.44--1.22) of Vit. D during pregnancy, quartiles 4.

  Schroth et al., (2014) \[[@B66-ijerph-17-00938]\]       RCS             Canada            207\                   M/F   \-\--          Vit. D\-\--                Serum Vit. D in pregnancy\                   None                                  Low serum Vit. D in pregnancy was statistically significantly associated ECC experience
                                                                                            mother-child\                                                          ECC\                                                                               
                                                                                            (\--)                                                                  Enamel defects                                                                     

  Zhang et al., (2014) \[[@B67-ijerph-17-00938]\]         CSS             Hong Kong         600\                   M/F   1 yy           Vit. C\                    Vit, C intake\                               None                                  OR for caries experience 1.75 (95%CI = 1.14--2.69) in girls Vit. C supplements
                                                                                            (12 yy)                                     tablets                    DMFT\                                                                              
                                                                                                                                                                   BEWE                                                                               

  Schroth et al., (2013) \[[@B68-ijerph-17-00938]\]       CCS             Canada            266\                   M/F   2 yy           Vit. D\                    Serum level Vit. D\                          None                                  Low Vit. D associated to high ECC levels
                                                                                            (\--)                                       \-\--                      ECC                                                                                

  MacKeown et al., (2003) \[[@B70-ijerph-17-00938]\]      CSS             South Africa      259\                   M/F   4 yy           Vit. A, B complex, C, D\   Vitamins intake\                             None                                  Vit. B2, B7, B12 statistically significantly associated to caries incidence
                                                                                            (2--5 yy)                                   diet                       dmft                                                                               

  Al Malik et al., (2001) \[[@B71-ijerph-17-00938]\]      CSS             Saudi Arabia      987\                   M/F                  Vit. C\                    Vit. C intake\                               None                                  Vit. C intake not statistically significantly significant associated to caries.
                                                                                            (2--5 yy)                                   \-\--                      dmft/s,\                                                                           
                                                                                                                                                                   Tooth Erosion                                                                      

  (**a**)                                                                                                                                                                                                                                             

  van der Tas et al., (2018) \[[@B59-ijerph-17-00938]\]   CS              the Netherlands   4750\                  M/F   \-\--          Vit. D\                    Foetal Vit. D\                               None                                  Vit. D not statistically significantly associated to MIH
                                                                                            (6 yy)                                      \-\--                      MIH at 6 yy                                                                        

  Reed et al., (2017) \[[@B62-ijerph-17-00938]\]          PS              USA               37\                    M/F   \-\--          Vit. D\                    Vit. D supplementation (first year of age)   None                                  Maternal pregnant Vit. D level statistically significantly associated to Enamel hypoplasia in children
                                                                                            (\--)                                       tablets                                                                                                       

  Kühnisch et al., (2017) \[[@B61-ijerph-17-00938]\]      RCS             Germany           406\                   M/F   10 yy          Vit. D\                    Vit. D supplementation\                      None                                  MIH not statistically significantly associated with Vit. D + Fluoride \<6 mo. OR = 1.71 (95%CI = 0.67--4.38) and Vit. D + fluoride \>6 mo. OR = 0.57 (95%CI = 0.21--1.55)
                                                                                            (at birth)                                  tablets                    Fluoride varnish\                                                                  
                                                                                                                                                                   MIH                                                                                

  Kühnisch et al., (2015) \[[@B64-ijerph-17-00938]\]      CSS             Germany           1148\                  M/F   10 yy          Vit. D\                    Vit. D supplémentation\                      None                                  MIH statistically significantly associated to 10 ng/mL of Vit. D increase OR 0.89 (95%CI = 0.82--0.97)
                                                                                            (\--)                                       tablets                    dmft/DMFT\                                                                         
                                                                                                                                                                   MIH                                                                                

  Schroth et al., (2014) \[[@B66-ijerph-17-00938]\]       RCS             Canada            207\                   M/F   \-\--          Vit. D\                    Serum Vit. D in pregnancy\                   None                                  Low serum Vit. D in pregnancy was statistically significantly associated ECC experience
                                                                                            mother-child\                               \-\--                      ECC\                                                                               
                                                                                            (\--)                                                                  Enamel defects                                                                     

  Zhang et al., (2014) \[[@B67-ijerph-17-00938]\]         CSS             Hong Kong         600\                   M/F   1 yy           Vit. C\                    Vit. C intake\                               None                                  Tooth erosion not statistically significantly associated to frequency of Vit. C supplement drinks (*p* = 0.064)
                                                                                            (12 yy)                                     diet                       DMFT\                                                                              
                                                                                                                                                                   BEWE                                                                               

  El Aidi et al., (2011) \[[@B69-ijerph-17-00938]\]       PS              the Netherlands   572\                   M/F   \-\--          Vitamins (unspecified)\    Vitamins intake\                             None                                  Vitamins intake statistically significantly associated to erosion progression OR = 2.03 (95%CI = 1.14--3.62)
                                                                                            (10--12 yy)                                 tablets                    Tooth Erosion                                                                      

  Al Malik et al., (2001) \[[@B71-ijerph-17-00938]\]      CSS             Saudi Arabia      987\                   M/F   \-\--          Vit. C\                    Vit. C intake\                               None                                  Vit. C intake statistically significantly associated to erosion.
                                                                                            (2--5-yy)                                   \-\--                      dmft/s,\                                                                           
                                                                                                                                                                   Tooth Erosion                                                                      

  Aine et al., (2000) \[[@B72-ijerph-17-00938]\]          CCS             Finland           96\                    M/F   \-\--          Vit. D\                    Vit. D supplementation\                      Preterm children                      Vit. D supplementation was not statistically significantly enamel defects.
                                                                                            (1--2 yy)                                   tablets                    Enamel defects                                                                     

  (**b**)                                                                                                                                                                                                                                             
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**DMFT/DMFS**: Decayed, Missing, Filled Tooth/Surfaces index in permanent teeth; **dmft/dmfs**: decayed, missing, filled footh/surfaces index in primary teeth; **MIH**: Molar Incisor Hypomineralization; **ECC**: Early Childhood Caries; **BEWE**: Basic Erosive Wear Examination; **95%CI**: Confidence Interval; **OR**: Odds Ratio; **yy**: age range in years.
